about
Immunogenetic mechanisms driving norovirus GII.4 antigenic variationPermeability and gating properties of human connexins 26 and 30 expressed in HeLa cellsEmergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunityPathogenetic role of the deafness-related M34T mutation of Cx26.Within-host evolution results in antigenically distinct GII.4 norovirusesIn-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Rational engineering of a human anti-dengue antibody through experimentally validated computational docking.Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].Serum Immunoglobulin A Cross-Strain Blockade of Human NorovirusesThe human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes.Rapid structural characterization of human antibody-antigen complexes through experimentally validated computational docking.A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.Impaired permeability to Ins(1,4,5)P3 in a mutant connexin underlies recessive hereditary deafness.Correction: Therapeutic Efficacy of Antibodies Lacking Fc. Receptor Binding against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies.Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune Evasion.Corrigendum to “Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes” [Virology 410 (2011) 240–247]
P50
Q24810360-B5AAA83D-8193-4360-9FAD-59C87B0A118FQ28206633-A70A0ACB-805C-4629-BD94-47F338ECFBAAQ30352529-B8047BC7-DDD1-4322-9CA2-AB17627123F3Q33691804-257064EE-C0D6-4059-8146-4645E5269D41Q33744124-F1B28469-B326-4D30-9D52-9D84EE77159CQ33945441-AFB5B6AD-EB52-41C7-BEC6-C2A349E45A73Q34059136-0F576B5F-4262-4570-B1E3-5C735E78951EQ34584319-30AE1F80-F6AF-4E3A-9838-A75CB80B3FCCQ34607919-07274ABA-88A7-4729-BD8F-6511754EC59AQ35837799-8F4A78FC-7508-49BB-A969-1023514E50BCQ37448171-0E37B5E4-57D4-42C9-B0FD-45D645932071Q40341498-E6EE7392-67DD-4FA6-B824-8EF375957465Q40369470-6522181F-F960-469D-894C-0F834500EAFBQ41596362-8B7B59D5-DAB6-4D04-9540-6034170E2E10Q45183609-BED2BA8C-85BD-4F39-80B2-A8C59E3C2A3CQ47103535-459F8782-AB30-4FD4-9036-83339244CBF6Q47105309-10E3FE40-9FB6-443F-B16C-F5D2D0BC1D4EQ49401911-3CD4062C-31F6-4953-B15E-D57CDA804B9DQ58667609-CDBCDC15-328B-40B6-867D-3CCA308DE5B5
P50
description
onderzoeker
@nl
name
Martina Beltramello
@ast
Martina Beltramello
@en
Martina Beltramello
@es
Martina Beltramello
@nl
Martina Beltramello
@sl
type
label
Martina Beltramello
@ast
Martina Beltramello
@en
Martina Beltramello
@es
Martina Beltramello
@nl
Martina Beltramello
@sl
prefLabel
Martina Beltramello
@ast
Martina Beltramello
@en
Martina Beltramello
@es
Martina Beltramello
@nl
Martina Beltramello
@sl
P214
P106
P21
P214
P31
P396
IT\ICCU\CFIV\275179
P569
2000-01-01T00:00:00Z
P735
P7859
viaf-307345241